Robert Gil

2 ta ish

Department of Invasive Cardiology, Central Clinical Hospital of the Ministry of the Interior, Warsaw, Poland Institute of Experimental and Clinical Medicine, Polish Academy of Science, Warsaw, Poland

1. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment

   Robert Gil, Jacek Bil, Tomasz Pawłowski +5

   MaqolaCoronary Interventions and DiagnosticsKardiologia Polska20160 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000135

2. One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

   Nabijon Yuldashev, Robert Gil, R. D. Kurbanov

   MaqolaCoronary Interventions and DiagnosticsInternational Journal of Biomedicine20180 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000491